Structure |
Chemical Name |
CAS |
MF |
|
Fasudil Impurity 6 |
2044706-58-1 |
C11H11NO3S |
|
Ibrutinib Impurity 11 |
|
|
|
Nintedanib impurity I |
334951-61-0 |
C30H31N5O4 |
|
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |
|
Everolimus Related Compound 3 |
147438-30-0 |
C32H49NO9 |
|
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1627824-09-2 |
C18H17F5NO5P |
|
Cefuroxime Sodium EP Impurity C |
69822-88-4 |
C15H15N3O6S |
|
Cefuroxime Sodium EP Impurity G |
97232-98-9 |
C17H17N3O8S |
|
2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone |
1244949-62-9 |
C11H14ClN3O |
|
Cetirizine 3-Chloro Impurity |
1232460-31-9 |
C21H25ClN2O3 |
|
Donepezil Impurity 8 |
1808997-65-0 |
C18H23NO4 |
|
Rivaroxaban Impurity 23 |
|
|
|
(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamide |
1450758-21-0 |
C5H6N4O2S |
|
Fosfomycin Trometamol impurity C |
23001-39-0 |
C4H12NO6P |
|
(R)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate |
|
C22H23FN2O5 |
|
1-(7,8-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1822601-94-4 |
C12H15N |
|
Sofosbuvir metabolites |
1859162-80-3 |
C16H18FN2O8P |
|
1,3,5,7-tetrahydroxyadamantane |
16104-28-2 |
C10H16O4 |
|
Cabozantinib Impurity E |
|
|
|
Loxoprofen Impurity I |
|
|
|
Sofosbuvir Impurity22 |
|
|
|
Donepezil Impurity-OH |
148517-82-2 |
C11H12O4 |
|
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one |
13491-41-3 |
C9H13N3O6 |
|
5-(hydroxymethyl)-3-[(5-nitro-2-furyl)methylideneamino]oxazolidin-2-one |
41359-15-3 |
C9H9N3O6 |
|
1-(2-amino-4,5-dimethoxyphenyl)ethan-1-one |
1071574-51-0 |
C10H13NO3 |
|
2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole |
103577-40-8 |
C16H14F3N3OS |
|
Ethyl (3E)-3-(2-phenylhydrazin-1-ylidene)butanoate |
6078-46-2 |
C12H16N2O2 |
|
1-(5,6-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1824506-44-6 |
C12H15N |
|
(S)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one hydrochloride |
1403383-55-0 |
C13H20ClN3O3 |
|
Terbutaline Impurity |
882066-15-1 |
C33H35NO3.H2O4S |
|
Bis(4-fluorobenzyl)aMine |
646051-52-7 |
C14H13F2N |
|
2-(2-butyl-4-methyl-1-((2'-(1-methyl-
1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide
2-(2-butyl-4-methyl-1-((2'-(2-methyl-
2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyri |
|
|
|
ethyl 1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylate |
|
C22H26FN3O4 |
|
(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid |
59413-21-7 |
C20H25N2NaO3 |
|
BDJS-SH 1 |
36588-45-1 |
C12H18N2O2 |
|
Blonanserin impurity A |
|
|
|
Captopril impurity 2 |
|
|
|
Ciprofloxacin Impurity D HCl |
526204-10-4 |
C17H18FN3O3 |
|
Clindamycin Impurity 6 |
|
|
|
Dabigatran Impurity 5 |
|
|
|
DecitaBine Impurity 10 |
|
|
|
Empagliflozin Impurity 17 |
2452301-27-6 |
C23H28O7 |
|
Erlotinib Impurity 31 |
|
|
|
Everolimus impurity C |
|
|
|
Ezetimibe Impurity 28 |
|
|
|
FeBuxostat Impurity 30 |
|
|
|
Fluconazole Impurity 5 |
94952-36-0 |
C13H12F2N6O |
|
Fosaprepitant Impurity 2 |
|
|
|
Imidafenacin Impurity 4 |
503598-78-5 |
C16H18N2O |
|
Intedanib Impurity H |
|
|
|
Isavuconazole Impurity 16 |
|
|
|
Isavuconazole Impurity 4 |
|
|
|
Lenvatinib Impurity 4 |
|
C28H22ClN5O5 |
|
Linagliptin Impurity 45 |
|
|
|
MiraBegron Impurity F |
|
|
|
Moxifloxacin Impurity 19 |
|
|
|
Moxifloxacin Impurity 34 |
1824286-08-9 |
C9H7ClF2O3 |
|
Nifedipine Impurity J |
114709-68-1 |
C16H17N3O5 |
|
Oxiracetam Impurity I |
142274-07-5 |
C7H9NO4 |
|
PalBociclib Impurity 4 |
|
|
|
Plerixafor Impurity 4 |
|
|
|
Posaconazole Impurity 29 |
|
|
|
Posaconazole Impurity 34 |
|
|
|
Posaconazole Impurity 58 |
|
|
|
Pregabalin Impurity 4 |
1955498-14-2 |
C10H22ClNO2 |
|
Rabeprazole Impurity 17 |
|
|
|
SofosBuvir Impurity 14 |
|
|
|
sofosBuvir Impurity 34 |
|
|
|
SofosBuvir Impurity 50 |
|
|
|
SofosBuvir Impurity 56 |
|
|
|
Tofacitinib impurity T |
1092578-43-2 |
C16H20N6O |
|
Valsartan Impurity 39 |
|
C24H29N5O3 |
|
Donepezil Impurity |
844694-84-4 |
C24H31NO2 |
|
imp.E |
950781-89-2 |
C13H12F3N3O3 |
|
Lidocaine EP Impurity |
31785-64-5 |
C12H18N2O.ClH |
|
Prucalopride Impurity 1 |
1900715-96-9 |
C18H24ClN3O3 |
|
3-(5-CHLOROPYRID-2-YL)CARBAMOYLPYRAZINE-2-CARBOXYLIC ACID(WXG01564) |
43200-83-5 |
C11H7ClN4O3 |
|
Ampicillin Impurity Q |
|
|
|
Cefdinir Impurity PQ(CP) |
|
|
|
Cefdinir Impurity IJKL |
|
|
|
Ceftazidime Impurity A (EP) |
|
|
|
Oxacillin Sodium Impurity E(EP) |
|
|
|
Spectinomycin Impurity B |
|
|
|
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
|
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
|
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
|
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
|
Moxifloxacin EP Impurity D HCl |
|
|
|
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
|
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
|
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
|
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
|
LAT-NET |
607351-44-0 |
C25H39NO4 |
|
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
|
L-GLUCONO-1,5-LACTONE |
52153-09-0 |
C6H10O6 |
|
Fenofibric Acid 1-Carboxyl-1-methylethyl Ester |
1797121-54-0 |
C21H21ClO6 |
|
2-Chlor-4'-fluorbenzophenon |
1806-23-1 |
C13H8ClFO |
|
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
|
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
|
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid |
855661-71-1 |
C21H24FN3O4 |